Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Cancer Biology & Medicine|June 16, 2021
Prognostic significance of a combined and controlled nutritional status score and EBV-DNA in patients with advanced nasopharyngeal carcinoma: a long-term follow-up studyHui Lu, Shanshan Guo, Liting Liu, et al.International Journal of Cancer|February 24, 2025
Efficacy and optimal duration of maintenance immunotherapy following systemic chemoimmunotherapy and locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: A multicenter retrospective cohort studyYujun Hu, Tianzhu Lu, Hao Zhang, et al.Journal of the National Comprehensive Cancer Network : JNCCN|March 13, 2025
Locoregional Radiotherapy Candidates in de Novo Metastatic Nasopharyngeal Carcinoma: Real-World Insights in the Immunotherapy EraDongxiang Wen, Jing Jin, Jieyi Lin, et al.Oral Oncology|July 6, 2024
The efficacy of adjuvant chemotherapy in patients with different midpoint-radiotherapy Epstein-Barr virus DNA plasma loadsJie Chen, Hui Cheng, Yujing Liang, et al.Cancer Biology & Medicine|April 17, 2020
Establishment of a prognostic scoring model for regional recurrent nasopharyngeal carcinoma after neck dissectionXiaoyun Li, Chao Lin, Jinjie Yan, et al.Cancer Research|January 6, 2021
Targeting the IRAK1-S100A9 Axis Overcomes Resistance to Paclitaxel in Nasopharyngeal CarcinomaLizhen Liu, Sailan Liu, Peng Deng, et al.Cancer Communications (London, England)|November 2, 2018
Famitinib in combination with concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 1, open-label, dose-escalation StudyQiuyan Chen, Linquan Tang, Na Liu, et al.Pageof 2